Using magnetite nanoparticles, we have developed an intracellular hyperthermia system that achieves artificial local control of temperature within tumors in the human body. This hyperthermia treatment has produced unexpected biological responses, including overcoming thermotolerance due to specific heating of the tumor at high temperature, and an anti-tumor immune response induced by expression of heat shock proteins (HSPs). These results suggest that our hyperthermia system can kill not only heated tumors but also non-heated tumors, including metastatic cancer cells. We have investigated the role of HSP70, in order to elucidate the mechanism of immune induction by hyperthermia 1) 2). We discussed here a mechanism of the anti-cancer immune response induced by our intracellular hyperthermia using magnetite nanoparticles.
Intracellular hyperthermia using magnetite nanoparticles
Various heating methods have been applied in hyperthermia, including the use of hot water, capacitive heating and inductive heating 3-5). However, an inevitable technical problem with hyperthermia is the difficulty of uniformly heating only the tumor region to the required temperature without damaging normal tissue. Accordingly, some researchers have proposed the use of intracellular hyperthermia to achieve "tumor-specific hyperthermia system", and have developed submicron magnetic particles for this purpose 6) 7). Intracellular hyperthermia is based on the principle that a magnetic particle can generate heat by hysteresis loss under an alternating magnetic field (AMF). In 1979, Gordon et al first proposed the concept of intracellular hyperthermia using dextran magnetite (Fe3O4) nanoparticles 8). We have We observed antitumor immune response induced by hyperthermia using MCLs in an experimental T-9 rat glioma model in which a tumor was transplanted into each femur of a rat ( Fig.2) 18 ).
Interestingly, although only one tumor was subjected to hyperthermia, the other tumor also disappeared completely. Immunohistochemical assay revealed that NK cells and CD8-and CD4-positive T cells migrated into the tumors after the hyperthermia treatment 18). These results suggest that the therapeutic magnetite nanoparticles are potentially effective tools for hyperthermia, because in addition to killing tumor cells with heat, they induce a host immune response. As a mechanism for recognition of tumor antigens by the host immune system, we have proposed heat shock protein (HSP) -mediated antitumor immunity. Because hyperthermia is a physical treatment, it is likely to have fewer side effects than chemotherapy.
Consequently, an advantage of hyperthermia is the feasibility of frequent repeated treatment 14)
However, conventional hyperthermia systems involve treatment only once or twice per week, performed at an interval of more than 48 h, to prevent thermotolerance 21 cell is derived from normal cell that is "self' originally. Matzinger proposed the "Danger model", which suggests that the immune system is more concerned with damage than with foreignness 38). In the "Danger model" , HSPs are considered an important "Danger signal". In particular, when HSPs, which are stress-indicators and normally present in cytoplasm, are released into the bloodstream, they can act as a signal to the immune system of an abnormal situation. We demonstrated that HSP70 expression following hyperthermia using MCLs induced antitumor immunity in rats with T-9 rat glioma 18).
Because MCLs are themselves heated in our hyperthermia system, the distribution of magnetite nanoparticles within tumors is an important issue. When MCLs were repeatedly heated, the surrounding tumor tissues underwent necrosis, and magnetite nanoparticles subsequently expanded into the necrosis area within the tumor, resulting in wide distribution of magnetite nanoparticles. Thus, the entire tumor area was necrosed by repeated (3 times) hyperthermia (with a 24-h interval over 3 days) 2). The 24-h interval corresponded to the time when HSP70 expression in T-9 cells reached its maximum, and a large amount of HSP70 was detected in the tumor tissue. Thus, our hyperthermia system using MCLs overcame thermotolerance and induced necrotic cell death that correlated with HSP70 expression. A reason why necrotic cell death via HSP70 expression is effective for cancer therapy is that necrotic cell death may strongly induce a "Danger signal". We observed that numerous and diverse kinds of These results suggest that our hyperthermia system confers antitumor immunity via release of HSP70-peptide complexes during necrotic tumor cell death in vivo. This phenomenon, which may be ( 6 ) 
